Safety and Efficacy of WC2031 Versus Vibramycin for the Treatment of Uncomplicated Urogenital Chlamydia Trachomatis Infection: A Randomized, Double-blind, Double-dummy, Active-controlled, Multicenter Study.

Trial Profile

Safety and Efficacy of WC2031 Versus Vibramycin for the Treatment of Uncomplicated Urogenital Chlamydia Trachomatis Infection: A Randomized, Double-blind, Double-dummy, Active-controlled, Multicenter Study.

Completed
Phase of Trial: Phase III

Latest Information Update: 19 Mar 2012

At a glance

  • Drugs Doxycycline hyclate (Primary)
  • Indications Chlamydial infections
  • Focus Therapeutic Use
  • Sponsors Warner Chilcott
  • Most Recent Events

    • 19 Mar 2012 Results published in Clinical Infectious Diseases.
    • 21 Dec 2011 Actual patient number (495) added as reported by ClinicalTrials.gov.
    • 04 Nov 2010 Status changed from active, no longer recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top